Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Jiangsu Recbio Technology Co., Ltd. Class H ( (HK:2179) ) has provided an announcement.
Jiangsu Recbio Technology Co., Ltd. has established an audit committee as part of its board to enhance decision-making, improve internal controls, and ensure effective supervision and management. The committee, composed mainly of independent non-executive directors with financial expertise, will oversee financial reviews, internal audits, and risk assessments, thereby strengthening the company’s governance structure.
The most recent analyst rating on (HK:2179) stock is a Sell with a HK$5.50 price target. To see the full list of analyst forecasts on Jiangsu Recbio Technology Co., Ltd. Class H stock, see the HK:2179 Stock Forecast page.
More about Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates in the biotechnology industry, focusing on developing and providing innovative biopharmaceutical products and services. The company is listed on the Hong Kong Stock Exchange under the stock code 2179.
Average Trading Volume: 39,478
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.69B
For an in-depth examination of 2179 stock, go to TipRanks’ Overview page.